Nobivac NXT FeLV, Feline Leukemia Vaccine, RNA Particle, 0.5 mL

Supplied By: Merck (212404)


SKU
084154


Unit of
Measure
25 x 1 Dose


Pack
Type
Tray


Case
Qty
10

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024
{{purchaseHistoryItem}}


SKU
084154


Size
25 x 1 Dose

Case
Qty
10

Purchase History

Jan- 2025 {{productPurchaseHistory['084154'][0]}} Jun- 2024 {{productPurchaseHistory['084154'][0+7]}}
Dec- 2024 {{productPurchaseHistory['084154'][1]}} May- 2024 {{productPurchaseHistory['084154'][1+7]}}
Nov- 2024 {{productPurchaseHistory['084154'][2]}} Apr- 2024 {{productPurchaseHistory['084154'][2+7]}}
Oct- 2024 {{productPurchaseHistory['084154'][3]}} Mar- 2024 {{productPurchaseHistory['084154'][3+7]}}
Sep- 2024 {{productPurchaseHistory['084154'][4]}} Feb- 2024 {{productPurchaseHistory['084154'][4+7]}}
Aug- 2024 {{productPurchaseHistory['084154'][5]}} Jan- 2024 {{productPurchaseHistory['084154'][5+7]}}
Jul- 2024 {{productPurchaseHistory['084154'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Nobivac® NXT FeLV is a non-adjuvanted, freeze-dried injectable feline leukemia virus vaccine, utilizing RNA particle technology. This product has been shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline leukemia virus. Duration of immunity is at least 2 years. To review efficacy and safety data, go to productdata.aphis.usda.gov. This product has been shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.

Features & Benefits

  • No extraneous material: Delivers comprehensive immunity in an adjuvant-free, preservative-free, thimerosal-free formulation
  • A gentle formulation: Low-volume 0.5-mL dose for a better overall vaccine experience
  • Robust efficacy: Next-level protection that outperforms PUREVAX® FeLV
  • Multi-layered protection: Stimulates a complete immune system response with an extended, 2-year duration of immunity


Trademarks are the property of their respective owners.